Combination antiretroviral therapy.

about

Pseudomonas DING proteins as human transcriptional regulators and HIV-1 antagonists.Challenges to antiretroviral therapy: can one sentence in medication labelling reduce adherence?

P2860

Q39125736-1E1B5B97-E69C-4F22-A304-943575AAC080 Q43498897-64117201-26A7-4B64-8507-6EF2F9A1FBE8

P2860

Combination antiretroviral therapy.

Item

http://www.wikidata.org/entity/Q51720301

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Combination antiretroviral therapy.

@en

Combination antiretroviral therapy.

@nl

type

Item

label

Combination antiretroviral therapy.

@en

Combination antiretroviral therapy.

@nl

prefLabel

Combination antiretroviral therapy.

@en

Combination antiretroviral therapy.

@nl

P1476

Combination antiretroviral therapy.

@en

P2093

Pere Domingo

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.

Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug r

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy

HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy

HIV infection is associated with an increased risk for lung cancer, independent of smoking.

Landmark article Aug 12, 1944: Penicillin in the treatment of meningitis. By D.H. Rosenberg and P.A.Arling.

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Pharmacokinetics, efficacy, and safety of darunavir/ritonavir 800/100 mg once-daily in treatment-naïve and -experienced patients.

Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions.

P304

995-998

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1517/14656566.2011.567001

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Francesc Vidal

P577

2011-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50849235

http://www.w3.org/2001/XMLSchema#string

P698

21434758

http://www.w3.org/2001/XMLSchema#string

Combination antiretroviral therapy.

about

P2860

P2860

Combination antiretroviral therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698